]>
IRCT201603093210N13 IRCT 2017-02-09 Maria Tavakoli-Ardakani Evaluation the effect of azithromycin oral suspension on the mucositis in patients undergoing Hematopoietic Stem Cell Transplantation Evaluation the effect of azithromycin oral suspension on the prevention and treatment of mucositis in Hematopoietic Stem Cell Transplant recipients 2015-12-31 anticipated 60 Complete https://irct.ir/trial/3263 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A • C00-D49 Neoplasms. Azithromycin oral suspension 300mg twice daily from first day of chemotherapy until engraftment day plus standard supportive care for mucositis in intervention group versus standard care of mucositis in control group..
public Mohadeseh Zeraatkar
Vali-e Asr Ave., Niayesh junction
Tehran Iran (Islamic Republic of) +98 912 687 5781 m2zeraatkar@gmail.com Students Research committee, School of pharmacy, Shahid Beheshti University of Medical Sciences scientific Maria Tavakoli-Ardakani
Vali-e Asr Ave., Niayesh junction
Tehran Iran (Islamic Republic of) +98 21 8887 3704 mariatavakoli@sbmu.ac.ir clinical pharmacy department, scholl of pharmacy & pharmaceutical sciences research center, Shahid B Iran (Islamic Republic of) Inclusion criteria: All patients hospitalized in bone marrow transplantation and patients undergoing chemotherapy;Patients satisfaction to participate in the study The exclusion criteria: Unwillingness of patients to continue;Allergic reactions to medication or other subunits of mouthwash 12 years 70 years Both Treatment - Drugs Azithromycin oral suspension 300mg twice daily from first day of chemotherapy until engraftment day plus standard supportive care for mucositis in intervention group versus standard care of mucositis in control group. Mucositis. Timepoint: first day of chemotherapy until engraftment day. Method of measurement: WHO scoring system. Fever grade. Timepoint: From the first day of chemotherapy until engraftment time. Method of measurement: Submit a fever above 38.5 ° C for patients. The need fortotal parenteral nutrition(TPN). Timepoint: During the study period. Method of measurement: SignTthe daysof parenteral nutrition intake. Maria Tavakoli-Ardakani Approved 2010-09-23 Ethics Committee of the Faculty of Pharmacy, University shahid Beheshti niyayesh.vali-asr tehran Iran (Islamic Republic of)